OBJECTIVE:Therapist adherence has been shown to predict clinical outcomes in family therapy. In prior studies, adherence has been represented broadly by core principles and a consistent family (vs. individual) focus. To date, these studies have not captured the range of clinical skills that are represented in complex family-based approaches or examined how variations in these skills predict different clinically relevant outcomes over the course of treatment. In this study, the authors examined the reliability and validity of an observational adherence measure and the relationship between adherence and outcome in a sample of drug-using adolescents who received brief strategic family therapy within a multisite effectiveness study. METHOD:Participants were 480 adolescents (age 12-17) and their family members, who were randomized to the Brief Strategic Family Therapist treatment condition (J. Szapocznik, U. Hervis, & S. Schwartz, 2003) or treatment as usual. The adolescents were mostly male (377vs. 103 female) and Hispanic (213), whereas 148 were White, and 110 were Black. Therapists were also randomly assigned to treatment condition within agencies. RESULTS: Results supported the proposed factor structure of the adherence measure, providing evidence that it is possible to capture and discriminate between distinct dimensions of family therapy. Analyses demonstrated that the mean levels of the factors varied over time in theoretically and clinically relevant ways and that therapist adherence was associated with engagement and retention in treatment, improvements in family functioning, and reductions in adolescent drug use. CONCLUSIONS: Clinical implications and future research directions are discussed, including the relevance of these findings on training therapists and studies focusing on mechanisms of action in family therapy.
RCT Entities:
OBJECTIVE: Therapist adherence has been shown to predict clinical outcomes in family therapy. In prior studies, adherence has been represented broadly by core principles and a consistent family (vs. individual) focus. To date, these studies have not captured the range of clinical skills that are represented in complex family-based approaches or examined how variations in these skills predict different clinically relevant outcomes over the course of treatment. In this study, the authors examined the reliability and validity of an observational adherence measure and the relationship between adherence and outcome in a sample of drug-using adolescents who received brief strategic family therapy within a multisite effectiveness study. METHOD:Participants were 480 adolescents (age 12-17) and their family members, who were randomized to the Brief Strategic Family Therapist treatment condition (J. Szapocznik, U. Hervis, & S. Schwartz, 2003) or treatment as usual. The adolescents were mostly male (377 vs. 103 female) and Hispanic (213), whereas 148 were White, and 110 were Black. Therapists were also randomly assigned to treatment condition within agencies. RESULTS: Results supported the proposed factor structure of the adherence measure, providing evidence that it is possible to capture and discriminate between distinct dimensions of family therapy. Analyses demonstrated that the mean levels of the factors varied over time in theoretically and clinically relevant ways and that therapist adherence was associated with engagement and retention in treatment, improvements in family functioning, and reductions in adolescent drug use. CONCLUSIONS: Clinical implications and future research directions are discussed, including the relevance of these findings on training therapists and studies focusing on mechanisms of action in family therapy.
Authors: Howard A Liddle; Cynthia L Rowe; Tanya J Quille; Gayle A Dakof; Dana Scott Mills; Eve Sakran; Hector Biaggi Journal: J Subst Abuse Treat Date: 2002-06
Authors: Scott W Henggeler; Sonja K Schoenwald; Jason G Liao; Elizabeth J Letourneau; Daniel L Edwards Journal: J Clin Child Adolesc Psychol Date: 2002-06
Authors: Daniel J Feaster; Michael S Robbins; Craig Henderson; Viviana Horigian; Marc J Puccinelli; A Kathy Burlew; José Szapocznik Journal: J Subst Abuse Treat Date: 2010-06
Authors: Michael S Robbins; José Szapocznik; Viviana E Horigian; Daniel J Feaster; Marc Puccinelli; Petra Jacobs; Kathy Burlew; Robert Werstlein; Ken Bachrach; Greg Brigham Journal: Contemp Clin Trials Date: 2009-01-18 Impact factor: 2.226
Authors: Michael S Robbins; Daniel J Feaster; Viviana E Horigian; Michael Rohrbaugh; Varda Shoham; Ken Bachrach; Michael Miller; Kathleen A Burlew; Candy Hodgkins; Ibis Carrion; Nancy Vandermark; Eric Schindler; Robert Werstlein; José Szapocznik Journal: J Consult Clin Psychol Date: 2011-10-03
Authors: Stacy R Ryan; Phillippe B Cunningham; Sharon L Foster; Patricia A Brennan; Rebecca L Brock; Elizabeth Whitmore Journal: J Child Fam Stud Date: 2013-01-01
Authors: Carlos Gallo; Hilda Pantin; Juan Villamar; Guillermo Prado; Maria Tapia; Mitsunori Ogihara; Gracelyn Cruden; C Hendricks Brown Journal: Adm Policy Ment Health Date: 2015-09
Authors: Joseph Guydish; Barbara K Campbell; Jennifer K Manuel; Kevin L Delucchi; Thao Le; K Michelle Peavy; Dennis McCarty Journal: Drug Alcohol Depend Date: 2013-11-04 Impact factor: 4.492
Authors: Aaron Hogue; Molly Bobek; Sarah Dauber; Craig E Henderson; Bryce D McLeod; Michael A Southam-Gerow Journal: J Child Adolesc Subst Abuse Date: 2017-05-23